Menopur Market Report 2026

Menopur Market Overview

• The Menopur market growth in the historic period has been driven by increasing infertility rates, expansion of ivf treatment availability • Market expansion is supported by increasing adoption of personalized fertility protocols, rising demand for home-based fertility treatment support • Growth Driver: Rising Infertility Rates Driving Market Growth For Fertility Treatments • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Menopur Market?

Menopur is a fertility medication that contains human menopausal gonadotropin (hMG), which includes luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Menopur is primarily used to treat certain fertility problems in women, particularly those undergoing Assisted Reproductive Technology (ART) procedures such as in vitro fertilization (IVF). It helps stimulate the development of multiple ovarian follicles, increasing the chances of successful egg retrieval and fertilization. The main indication in the menopur market are infertility treatment and hypogonadism. Infertility treatment refers to medical interventions, therapies, or procedures designed to assist individuals or couples in achieving pregnancy and overcoming challenges associated with infertility. Various formulations include injectable solution and pre-filled syringes. The various distribution channels include hospital pharmacies, specialty clinics, retail pharmacies, and online pharmacies and, several end users encompass women and men.

What Is The Menopur Market Growth Forecast?

The growth in the forecast period can be attributed to increasing adoption of personalized fertility protocols, rising demand for home-based fertility treatment support, expansion of global fertility tourism, growing investments in reproductive health services, increasing focus on treatment success rate optimization. Major trends in the forecast period include increasing use of assisted reproductive technology treatments, rising adoption of hormonal fertility therapies, growing demand for injectable gonadotropin medications, expansion of fertility clinic networks, enhanced focus on optimized ovarian stimulation protocols.

What Are The Drivers Of The Menopur Market?

The increase in the prevalence of infertility is expected to drive the growth of the menopur market going forward. Infertility is referred to as the inability to achieve pregnancy after a year of regular, unprotected intercourse. The increasing prevalence of infertility is primarily due to lifestyle changes, environmental pollutants, and delayed childbearing. Menopur is beneficial for infertility to help stimulate the ovaries to produce multiple eggs, increasing the chances of conception. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 17.5% of the adult population, or about 1 in 6 people globally, face infertility, highlighting the pressing need to improve access to affordable, high-quality fertility care for those affected. Therefore, the increase in the prevalence of infertility is driving the growth of the menopur industry. The increase in healthcare spending is expected to drive the growth of the menopur market going forward. Healthcare spending refers to the financial resources allocated to provide healthcare services. The increasing healthcare spending is attributed to factors such as aging populations, the rising prevalence of chronic diseases, advancements in medical technology, and the growing demand for more specialized and personalized care. Menopur is beneficial for healthcare spending by providing an effective fertility treatment option, potentially reducing the need for prolonged or multiple cycles of assisted reproductive technologies, thus optimizing treatment costs. For instance, In May 2024, according to a report published by the Office for National Statistics, a UK-based government department for official statistics, total healthcare expenditure in the UK saw a 5.6% increase in nominal terms from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. Therefore, the increase in healthcare spending is driving the growth of the menopur industry. The increase in maternal age is expected to drive the growth of the menopur market going forward. Maternal age is the age of a woman when she becomes pregnant or gives birth, affecting fertility and pregnancy health. The increase in maternal age is attributed to factors such as delayed marriage, career prioritization, and advancements in fertility treatments that allow women to have children later in life. Menopur is beneficial for women of advanced maternal age, which stimulates the ovaries to produce multiple eggs, improving the chances of conception despite age-related declines in fertility. For instance in April 2025 accroding to the The Office for National Statistics (ONS) a UK-based independent producer of official statistics in 2023, the average age of women in England and Wales at childbirth (standardised mean age of a mother) was 30.9 years. Therefore, the increase in maternal age is driving the growth of the menopur industry.

Key Players In The Global Menopur Market

Major companies operating in the menopur market are Ferring Pharmaceuticals

What Defines the Menopur Market?

The menopur market consists of sales of menopur injection (hMG), menopur pre-filled syringes and menopur vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Menopur Market Report 2026?

The menopur market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the menopur industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.